References
- Vanlersberghe C, Camu F. Propofol. Handbook Exp Pharmacol. 2008;182:227–252.
- Vasileiou I, Xanthos T, Koudouna E, et al. Propofol: a review of its non-anaesthetic effects. Eur J Pharmacol. 2009;605(1–3):1–8.
- Hofbauer R, Frass M, Salfinger H, et al. Propofol reduces the migration of human leukocytes through endothelial cell monolayers. Crit Care Med. 1999;27:1843–1847.
- Duarte DB, Vasko MR, Fehrenbacher JC. Models of inflammation: carrageenan air pouch. Curr Protoc Pharmacol. 2012;Chapter 5:Unit5.6. DOI:10.1002/0471141755.ph0506s56
- Sin YM, Sedgwick AD, Chea EP, et al. Mast cells in newly formed lining tissue during acute inflammation: a six day air pouch model in the mouse. Ann Rheum Dis. 1986;45(10):873–877.
- Martin SW, Stevens AJ, Brennan BS, et al. The six-day-old rat air pouch model of inflammation: characterization of the inflammatory response to carrageenan. J Pharmacol Toxicol Methods. 1994;32(3):139–147.
- Romano M, Faggioni R, Sironi M, et al. Carrageenan-induced acute inflammation in the mouse air pouch synovial model. Role of tumour necrosis factor. Mediators Inflamm. 1997;6(1):32–38.
- Inada T, Asai T, Yamada M, et al. Propofol and midazolam inhibit gastric emptying and gastrointestinal transit in mice. Anesth Alalg. 2004;99:1102–1106.
- Inada T, Sumi C, Hirota K, et al. Mitigation of inflammation using the intravenous anesthetic dexmedetomidine in the mouse air pouch model. Immunopharmacol Immunotoxicol. 2017;39(4):225–232.
- García-Ramallo E, Marques T, Prats N, et al. Resident cell chemokine expression serves as the major mechanism for leukocyte recruitment during local inflammation. J Immunol. 2002;169(11):6467–6473.
- Jia J, Sun Y, Hu Z, et al. Propofol inhibits the release of interleukin-6, 8, and tumor necrosis factor-α correlating with high-mobility group box 1 expression in lipopolysaccharides-stimulated RAW264.7 cells. BMC Anesthesiol. 2017;17(1):148.
- Wei L, Matsumoto H, Yamaguchi H. Propofol attenuates lipopolysaccharide-induced monocyte chemoattractant protein-1 production through p38 MAPK and SAPK/JNK in alveolar epithelial cells. J Anesth. 2013;27(3):366–373.
- Kochiyama T, Li X, Nakayama H, et al. Effect of propofol on the production of inflammatory cytokines by human polarized macrophages. Mediators Inflamm. 2019;2019:1919538.
- Inada T, Ueshima H, Shingu K. Intravenous anesthetic propofol suppresses leukotriene production in murine dendritic cells. J Immunotoxicol. 2013;10(3):262–269.
- Inada T, Hirota K, Shingu K. Intravenous anesthetic propofol suppresses prostaglandin E2 and cysteinyl leukotriene production and reduces edema formation in arachidonic acid-induced ear inflammation. J Immunotoxicol. 2015;12(3):261–265.